25 results
PRE 14A
SQZB
SQZ Biotechnologies Co
10 Apr 23
Preliminary proxy
4:31pm
Firm Fees and Other Matters
Executive Officers
Corporate Governance
Committees of the Board
Executive and Director Compensation
Delinquent Section 16 … stockholders and believe that stockholder ratification of our appointment is a good corporate governance practice.
PricewaterhouseCoopers LLP also served
8-K
SQZB
SQZ Biotechnologies Co
6 Sep 22
SQZ Biotechnologies Announces Leadership Transition
4:33pm
.
Additionally, on September 1, 2022, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed Dr
8-K/A
l01uf53 w9
29 Jul 21
Departure of Directors or Certain Officers
5:00pm
8-K
EX-99.1
ctay42rspxci
1 Jul 21
SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience
5:07pm
8-K
ly7oh4 znurf
1 Jul 21
SQZ Biotechnologies Strengthens Board with Global Commercial and Clinical Development Experience
5:07pm
DEF 14A
yp1sq9l p1a
26 Apr 21
Definitive proxy
5:00pm
10-K
rkpfm6gicqb
18 Mar 21
Annual report
6:31am
424B4
4kw1sh97sz
12 Feb 21
Prospectus supplement with pricing info
5:10pm
DRS
pio12mq9m12
1 Feb 21
Draft registration statement
12:00am
10-Q
410y2va3roesh7
10 Dec 20
Quarterly report
4:46pm
424B4
gtono13h 9kog22v7qc
30 Oct 20
Prospectus supplement with pricing info
4:54pm